BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16788344)

  • 1. Comparison of Short Form-36 and Migraine Disability Assessment questionnaire in patients with migraine.
    Fuh JL; Wang SJ
    Clin J Pain; 2006; 22(6):564-8. PubMed ID: 16788344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
    Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
    Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIDAS and HIT-6 French translation: reliability and correlation between tests.
    Magnoux E; Freeman MA; Zlotnik G
    Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability and quality of life in different primary headaches: results from Italian studies.
    Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
    Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
    Kilminster SG; Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D
    Headache; 2006 Apr; 46(4):553-62. PubMed ID: 16643548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
    Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
    Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIDAS questionnaire modification for a new MIDAS junior questionnaire: a clinical experience at the Neurological Institute "C. Besta".
    Grazzi L
    Neurol Sci; 2004 Oct; 25 Suppl 3():S261-2. PubMed ID: 15549553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire.
    Lipton RB; Stewart WF; Sawyer J; Edmeads JG
    Headache; 2001 Oct; 41(9):854-61. PubMed ID: 11703471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine.
    Gedikoglu U; Coskun O; Inan LE; Ucler S; Tunc T; Emre U
    Cephalalgia; 2005 Jun; 25(6):452-6. PubMed ID: 15910570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the impact of vision impairment.
    Weih LM; Hassell JB; Keeffe J
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):927-35. PubMed ID: 11923230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIDAS questionnaire in the emergency setting.
    Aliprandi A; Frigerio R; Santoro P; Frigo M; Iurlaro S; Vaccaro M; Tremolizzo L; Beghi E; Ferrarese C; Agostoni E
    Neurol Sci; 2004 Oct; 25 Suppl 3():S274-5. PubMed ID: 15549558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
    Haro H; Maekawa S; Hamada Y
    Spine J; 2008; 8(2):380-4. PubMed ID: 17433781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability in young patients suffering from primary headaches.
    Grazzi L; D'Amico D; Usai S; Solari A; Bussone G
    Neurol Sci; 2004 Oct; 25 Suppl 3():S111-2. PubMed ID: 15549516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
    D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
    Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
    Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
    Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.
    Usai S; Grazzi L; Andrasik F; D'Amico D; Rigamonti A; Bussone G
    Neurol Sci; 2004 Oct; 25 Suppl 3():S272-3. PubMed ID: 15549557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting disability and quality of life in a community-based sample of women with migraine headache.
    Kolotylo CJ; Broome ME
    Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.